Antidiabetic and Thrombolytic Effects of Ethanolic Extract of Spilanthes paniculata Leaves
Journal of Plant Sciences
Volume 2, Issue 6-1, December 2014, Pages: 13-18
Received: Dec. 21, 2014;
Accepted: Dec. 27, 2014;
Published: Mar. 14, 2015
Views 3571 Downloads 186
Shamima Akter, Department of Pharmacy, Southeast University, Dhaka, Bangladesh
Md. Ataur Rahman, Department of Pharmacy, Southeast University, Dhaka, Bangladesh
Md. Abul Kalam Azad, Department of Pharmacy, Southeast University, Dhaka, Bangladesh
Md. Mohiuddin, Department of Pharmacy, Southeast University, Dhaka, Bangladesh
Abdullah Al Mamun, Department of Pharmacy, Southeast University, Dhaka, Bangladesh
Jyotirmoy Sarker, Department of Pharmacy, Southeast University, Dhaka, Bangladesh
Mohammad Safiqul Islam, Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
Md. Shahid Sarwar, Department of Pharmacy, Southeast University, Dhaka, Bangladesh
Experimental studies explored the antidiabetic and thrombolytic effect of several Spilanthes species in various animal models, but previously no study was conducted to establish the antidiabetic and thrombolytic potentiality of Spilanthes paniculata. The present study investigate the antidiabetic and thrombolytic effects of ethanolic extract of Spilanthes paniculata leaves with the intention to find the drug for diabetes and thrombosis management from natural sources. The hypoglycemic effect of the extracts was tested in normal and alloxan-induced diabetic mice. Blood glucose level was measured according to glucose oxidase method. The thrombolytic activity was assessed by using human erythrocyte and the results were compared with standard streptokinase (SK). In the present research, the ethanolic extract of Spilanthes paniculata reduces the blood glucose level at a dose and time dependant manner. It was observed that the plant possess significant antidiabetic activity (P<0.05) at higher dose (450 mg/kg body weight) when compared with standard drug glibenclamide. The extract, at a dose of 150, 300 and 450 mg/kg body weight showed glucose reduction from 23.37±1.80, 20.1±2.60 and 17.13±1.36 initial levels to 11.07±1.98, 10.1±0.26 and 8.3±0.15 mmol/L after 8 hours respectively. In this study, the ethanolic extract of Spilanthes paniculata showed moderate clot lysis activity. The clot lysis activity of control, standard (streptokinase) and ethanolic extract of Spilanthes paniculata was 2.65%, 93.35% and 46.78% respectively. This study explored that ethanolic extract of Spilanthes paniculata leaves has potential antidiabetic and moderate thrombolytic activity.
Md. Ataur Rahman,
Md. Abul Kalam Azad,
Abdullah Al Mamun,
Mohammad Safiqul Islam,
Md. Shahid Sarwar,
Antidiabetic and Thrombolytic Effects of Ethanolic Extract of Spilanthes paniculata Leaves, Journal of Plant Sciences. Special Issue: Pharmacological and Biological Investigation of Medicinal Plants.
Vol. 2, No. 6-1,
2014, pp. 13-18.
R.K. Jansen, “ Syst Bot Monogr,” 1985, 8, p.110-5.
V. Pandey, V. Agrawal, K. Raghavendra and A.P. Das, “Strong larvicidal activity of three species of Spilanthes (Akarkara) against malaria ( Anopheles stephensi Liston, Anopheles culicifacies , species C) and filaria vector ( Culex quinquefasciatus Say),” Parasitol Res, 2007,102, p. 171–4.
S. Prachayasittikul, S. Suphapong, A. Worachartcheewan, R. Lawung, S. Ruchirawat, and V. Prachayasittikul, “Bioactive metabolites from Spilanthes acmella Murr,” Molecules, 2009, 14(2), p. 850–867.
N. Nakatani and M. Nagashima, “Pungent alkamides from Spilanthes acmella var. oleracea Clarke,” Bioscience, Biotechnology, and Biochemistry, 1992, 56(5), p. 759–762.
A. A. Sittie, E .Lemmich , C.E. Olsen, L. Hviid and S. Brøgger Christensen, “Alkamides from Phyllanthus fraternus,” In: Planta Medica, 1998, 64(2), p. 192-3.
M. Majumder, A.K. Shukla and A. Arunachalam, “Nutrient release and fungal succession during decomposition of weed residues in a shifting cultivation system,” Communications in Biometry and Crop Science, 2008, 3(1), p. 45–59.
D.M. Verma, N.P. Balakrishnan and R.D. Dixit, “Flora of Madhya Pradesh,” Botanical survey of India, Kolkata, India, 1993, 1, p. 612-613.
Available at: http://www.novanthealth.org/Portals/92/nh_presbyterian_medical_center/documents/about_us/bulletin_boards/april_2014_nutrition_management_diabetes_english.pdf (Accessed on 14 Dec. 2014).
J.N. Fisher, M.N. Shahshahani and A.E. Kitabchi, “Diabetic ketoacidosis: low-dose insulin therapy by various routes,” N Engl J Med, 1977, 297, p. 238.
C. David Klonoff, B. John Buse, L. Loretta, Nielsen, Xuesong Guan, L. Christopher Bowlus, H. John Holcombe, E. Matthew Wintle, and David G. Maggs, “Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years,” Informa healthcare, 2008, 24(1) , p. 275-286.
Available at: http://www.news-medical.net/health/What-is-Thrombosis.aspx9914. (Accessed on14 Dec.2014)
N. Alkjaersig, A.P. Fletcher and S. Sherry, “The mechanism of clot dissolution by plasmin,” J Clin Invest, 1959, 38(7), p. 1086–1095.
D. Collen, “Coronary thrombolysis: streptokinase or recombinanttissue-type plasminogen activator,” Annals of Internal Medicine, 1990, 112, p. 529–538.
A.S. Apu, F.A. Chowdhury, F. Khatun, A.T.M. Jamaluddin, A. Pathan and A. Pal, “Phytochemical Screening and In vitro Evaluation of Pharmacological Activities of Aphanamixis polystachya (Wall) Parker Fruit Extracts,” Tropical Journal of Pharmaceutical Research, 2013, 12(1), p. 111-116.
T. Capstick and M.T. Henry, “Efficacy of thrombolytic agents in the treatment of PE,” European Respiratory Journal, 2005, 26, p. 864-874.
B. Giuseppina, L .Cristiana, L .Guido, C. Piero, L.A. Antonio and R. Daniele, “Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. An in vitro study on blood of normal subjects and patients with coronary artery disease,” Journal of Thrombosis and Haemostasis, 2004, 91, p. 1078-1083.
D. Collen, “ Coronary thrombolysis: streptokinase or recombinanttissue-type plasminogen activator,” Ann Intern Med, 1990, 112, p. 529–538.
V.J. Marder, “Recombinant streptokinase –opportunity for an improved agent,”Blood Coagul Fibrinolysis, 1993, 4, p. 1039–1040.
F.J. Alarcon-Aguilar, M. Jimenez-Estrada, R. Reyes-Chilpa, B. GonzalezParedes, C. Contreras-Weber, and R. Roman-Ramos, “Hypoglycemic activity of root water decoction, sesquierpenoids, and one Polysaccharide fraction from Psacalium decompositum in mice”, Journal of Ethno-Pharmacology, 2000, 69, p. 207-15.
S. Dhandapani, S.V. Ramasamy, S. Rajagopal and N. Namasivayam, “Hypolipidemiceffect of Cuminum cyminum L. on alloxan-induced diabetic rats,” Pharmacol. Res, 2002, 46(3), p. 251-255.
S. Prasad, R.S. Kashyap, J.Y. Deopujari, H.J. Purohit, G.M. Taori, H.F. Daginawala “Effect of Fagonia arabica (Dhamasa) on in vitro thrombolysis,” BMC Complement Altern Med, 2007, 7, p. 36.
M. Goldner and G. Gomori, “Alloxan induced diabetes,” J Endocrinol, 1943, 33, p. 297–9.
L. Pari and M Latha, “Antidiabetic effect of Scoparia dulcis:Effect of lipid peroxidation in Streptozotocin diabetes,” Gen. Physiol. Biophys, 2005, 24, p. 13-26.